PharmaLex Norway AS is a company that offers specialized services for the pharmaceutical industry, with a focus on compliance and regulatory requirements. The company has a global presence and supports clients throughout the entire product life cycle. They provide insight and guidance on eCTD 4.0 and the EU MDR, which are important aspects within drug regulation.
In addition to advisory services, PharmaLex presents case studies that illustrate outsourcing and growth among specialty drug developers. The company has also carried out a transition to Cencora to improve its services, as well as focusing on optimizing revenues from mature products. PharmaLex Norway AS covers a wide range of functional areas within consultancy, which makes them a significant player in the industry.
